Roy Hartvig Larsen
Chief Executive Officer at Sciencons AS
Net worth: 199 920 $ as of 2024-03-30
Network origin in Roy Hartvig Larsen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
23
| Extinct | Pharmaceuticals: Major | 23 |
| Extinct | Pharmaceuticals: Major | 8 | |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Roy Hartvig Larsen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| TRANSGENE | Biotechnology | Director/Board Member | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| AQUA BIO TECHNOLOGY ASA | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Oslo Cancer Cluster NCE
 Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Founder Private Equity Investor | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| PHOTOCURE ASA | Medical Specialties | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Chairman | |
Odlander, Fredrikson & Co. AB
 Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
Radiumhospitalets Forskningsstiftelse
 Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
GE Healthcare AS
 GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| WEIFA ASA | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
| University of Oslo | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Graduate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Norwegian University of Science & Technology | College/University | Graduate Degree Graduate Degree | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
| Healthcap Annex Fund I-II GP AB | Chairman Director/Board Member | ||
| BONESUPPORT HOLDING AB | Medical Specialties | Director/Board Member Director/Board Member | |
Ostomycure AS
 Ostomycure AS Miscellaneous Commercial ServicesCommercial Services Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| SERODUS ASA | Biotechnology | Director/Board Member Director/Board Member | |
Healthcap 1999 GP AB
 Healthcap 1999 GP AB Investment Banks/BrokersFinance Part of Odlander, Fredrikson & Co. AB, Healthcap 1999 GP AB is a private company that manages and trades securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | President Director/Board Member | |
| BERGENBIO ASA | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
NVC Holding AB
 NVC Holding AB Investment Banks/BrokersFinance NVC Holding AB owns and manages shares in companies and real property. The company is headquartered in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
Calpro AS
 Calpro AS Miscellaneous Commercial ServicesCommercial Services Calpro AS is a Norwegian bio-tech company that specializes in researching and developing Calprotectin based diagnostic tests. The private company is based in Lysaker, Norway. The company's solutions include a comprehensive range of individual tests and test panels, as well as support for therapeutic drug monitoring. | Miscellaneous Commercial Services | Director/Board Member | |
| Calpro Diagnostics, Inc. | Director/Board Member | ||
| Jotunfjell AS | Director/Board Member | ||
| Magnus Innovasjon AS | Chief Executive Officer | ||
Oslo universitetssykehus HF
 Oslo universitetssykehus HF Hospital/Nursing ManagementHealth Services Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
| CIRCIO HOLDING ASA | Biotechnology | Director/Board Member Chairman Director/Board Member | |
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Detroit Mercy School of Law | College/University | Graduate Degree | |
Shionogi Ltd.
 Shionogi Ltd. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi Ltd. is a British company that manufactures and distributes pharmaceutical products. The private company is based in London, UK. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| CYXONE AB | Pharmaceuticals: Major | Director/Board Member | |
Healthcap Orx Holdings Gp AB
 Healthcap Orx Holdings Gp AB Investment Banks/BrokersFinance Healthcap Orx Holdings Gp AB is a private company that manages securities. The company is based in Stockholm, Sweden. | Investment Banks/Brokers | Chairman Director/Board Member | |
| Biovotec A/S | Director/Board Member | ||
Healthcap Annex Fund I-Ii Bis Gp AB
 Healthcap Annex Fund I-Ii Bis Gp AB Financial ConglomeratesFinance Healthcap Annex Fund I-Ii Bis Gp AB operates as an investment holding Swedish company. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Chairman Director/Board Member | |
| Mylifeproducts AS | Chairman | ||
Melius Pharma AB
 Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Pharmaceuticals: Major | Director/Board Member | |
Nordic Vision Clinics AS
 Nordic Vision Clinics AS Hospital/Nursing ManagementHealth Services Part of NVC Holding AB, Nordic Vision Clinics AS is a Norwegian company that provides laser eye surgery. The private company is based in Oslo, Norway. | Hospital/Nursing Management | Director/Board Member Director/Board Member |
Statistics
International
| Norway | 26 |
| Sweden | 14 |
| United States | 7 |
| France | 4 |
| Denmark | 3 |
Sectoral
| Health Technology | 26 |
| Finance | 8 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Health Services | 3 |
Operational
| Director/Board Member | 215 |
| Corporate Officer/Principal | 67 |
| Chairman | 48 |
| Independent Dir/Board Member | 46 |
| Chief Executive Officer | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Björn Ingemar Odlander | 53 |
| Per Anders Göte Samuelsson | 36 |
| Theresa Comiskey Olsen | 26 |
| Jean Bizzari | 24 |
| Hilde Hermansen Steineger | 24 |
| John Berriman | 24 |
| Ludvik Sandnes | 22 |
| Olav Steinnes | 18 |
| Renee Tannenbaum | 16 |
| Stein Holst Annexstad | 15 |
| Adrian M. Senderowicz | 13 |
| Tone Kvåle | 13 |
| Anders Månsson | 12 |
| Jónas Einarsson | 12 |
| Gisela Schwab | 12 |
- Stock Market
- Insiders
- Roy Hartvig Larsen
- Company connections